Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretrovir...

Por de la Rosa, Rafael, Pineda, Juan A, Delgado, Juan, Macías, Juan, Morillas, Francisco, Mira, José A., Sánchez-Quijano, Armando, Leal, Manuel, Lissen, Eduardo
Publicado em 2002

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

Por Neukam, Karin, Viciana, Pompeyo, Ojeda-Burgos, Guillermo, Delgado-Fernández, Marcial, Ríos, María J., Macías, Juan, Merino, Dolores, Collado, Antonio, Téllez, Francisco, Pineda, Juan A.
Publicado no BMC Infect Dis (2016)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients

Por Rivero-Juarez, Antonio, Gonzalez, Rafael, Camacho, Angela, Manzanares-Martin, Barbara, Caruz, Antonio, Martinez-Peinado, Antonio, Torre-Cisneros, Julian, Pineda, Juan A., Peña, José, Rivero, Antonio
Publicado em 2013

Prevalence of and Factors Associated with Visceral Leishmaniasis in Human Immunodeficiency Virus Type 1-Infected Patients in Southern Spain

Por Pineda, Juan A., Gallardo, José A., Macías, Juan, Delgado, Juan, Regordán, Carmen, Morillas, Francisco, Relimpio, Federico, Martín-Sánchez, Joaquina, Sánchez-Quijano, Armando, Leal, Manuel, Lissen, Eduardo
Publicado em 1998

Use of Noninvasive Markers To Detect Leishmania Infection in Asymptomatic Human Immunodeficiency Virus-Infected Patients

Por García-García, José A., Martín-Sánchez, Joaquina, Gállego, Montserrat, Rivero-Román, Antonio, Camacho, Angela, Riera, Cristina, Morillas-Márquez, Francisco, Vergara, Salvador, Macías, Juan, Pineda, Juan A.
Publicado em 2006

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection

Por Macías, Juan, López-Cortés, Luis F., Téllez, Francisco, Recio, Eva, Ojeda-Burgos, Guillermo, Ríos, MªJosé, Rivero-Juárez, Antonio, Delgado, Marcial, Jeremías, Rivas-, Pineda, Juan A.
Publicado no PLoS One (2015)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV

Por Rivero-Juárez, Antonio, Camacho, Angela, Merchante, Nicolás, Pérez-Camacho, Inés, Macias, Juan, Ortiz-Garcia, Carmen, Cifuentes, Celia, Torre-Cisneros, Julián, Peña, José, Pineda, Juan A., Rivero, Antonio
Publicado em 2013

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients

Por Rivero-Juarez, Antonio, López-Cortés, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Gordon, Ana, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Pineda, Juan A., Viciana, Pompeyo, Rivero, Antonio
Publicado em 2014

Reassessment of Genotype 1 Hepatitis C Virus Subtype Misclassification by LiPA 2.0: Implications for Direct-Acting Antiviral Treatment

Por Guelfo, Javier R., Macias, Juan, Neukam, Karin, Di Lello, Federico A., Mira, Jose A., Merchante, Nicolas, Mancebo, María, Nuñez-Torres, Rocío, Pineda, Juan A., Real, Luis M.
Publicado no J Clin Microbiol (2014)

Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients

Por López-Cortés, Luis F., Ruiz-Valderas, Rosa, Jimenez-Jimenez, Luis, González-Escribano, María F., Torres-Cornejo, Almudena, Mata, Rosario, Rivero, Antonio, Pineda, Juan A., Marquez-Solero, Manuel, Viciana, Pompeyo
Publicado em 2012

Short Communication: Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C

Por Rivero-Juarez, Antonio, Mira, Jose A., Santos-Gil, Ignacio, Lopez-Cortes, Luis F., Girón-Gonzalez, Jose A, Marquez, Manuel, Merino, Dolores, Tellez, Francisco, Caruz, Antonio, Pineda, Juan A, Rivero, Antonio
Publicado em 2013

Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment

Por Pérez-Elías, María J., Morellon, María Larrousse, Ortega, Enrique, Hernández-Quero, José, Rodríguez-Torres, Maribel, Clotet, Bonaventura, Felizarta, Franco, Gutiérrez, Felix, Pineda, Juan A., Nichols, Garrett, Lou, Yu, Wire, Mary Beth
Publicado em 2009

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

Por Rivero-Juárez, Antonio, Lopez-Cortes, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Pineda, Juan A., Marquez-Solero, Manuel, Caruz, Antonio, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Gutierrez-Valencia, Alicia, Rivero, Antonio
Publicado em 2012

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients

Por Núñez-Torres, Rocío, Macías, Juan, Mancebo, María, Frías, Mario, Dolci, Giovanni, Téllez, Francisco, Merino, Dolores, Merchante, Nicolás, Gómez-Mateos, Jesús, Guaraldi, Giovanni, Rivero-Juárez, Antonio, Pineda, Juan A., Real, Luis M.
Publicado no PLoS One (2016)

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

Por Real, Luis M., Macías, Juan, Pérez, Ana B., Merino, Dolores, Granados, Rafael, Morano, Luis, Delgado, Marcial, Ríos, María J., Galera, Carlos, Deltoro, Miguel G., Merchante, Nicolás, García, Federico, Pineda, Juan A.
Publicado no Sci Rep (2018)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians

Por Real, Luis M., Neukam, Karin, Herrero, Rocío, Guardiola, Josep M., Reiberger, Thomas, Rivero-Juarez, Antonio, Salazar, Juliana, Mandorfer, Mattias, Merino, Dolores, Soriano, Vicente, Rivero, Antonio, Macías, Juan, Pineda, Juan A., Caruz, Antonio
Publicado em 2014

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort

Por Neukam, Karin, Mira, José A., Collado, Antonio, Rivero-Juárez, Antonio, Monje-Agudo, Patricia, Ruiz-Morales, Josefa, Ríos, María José, Merino, Dolores, Téllez, Francisco, Pérez-Camacho, Inés, Gálvez-Contreras, María Carmen, Rivero, Antonio, Pineda, Juan A.
Publicado no PLoS One (2016)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

Por Real, Luis Miguel, Macías, Juan, Rivero-Juárez, Antonio, Téllez, Francisco, Merino, Dolores, Moreno-Grau, Sonia, Orellana, Adelina, Gómez-Salgado, Juan, Sáez, María E., Frías, Mario, Corma-Gómez, Anaïs, Merchante, Nicolás, Ruiz, Agustín, Caruz, Antonio, Pineda, Juan A.
Publicado no Sci Rep (2019)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis

Por Merchante, Nicolás, Téllez, Francisco, Rivero-Juárez, Antonio, Ríos-Villegas, Maria José, Merino, Dolores, Márquez-Solero, Manuel, Omar, Mohamed, Recio, Eva, Pérez-Pérez, Montserrat, Camacho, Ángela, Macías-Dorado, Sara, Macías, Juan, Lorenzo-Moncada, Sandra, Rivero, Antonio, Pineda, Juan A.
Publicado no BMC Infect Dis (2015)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study

Por Neukam, Karin, Espinosa, Nuria, Merino, Dolores, Rivero-Juárez, Antonio, Carrero, Ana, José Ríos, María, Ruiz-Morales, Josefa, Gómez-Berrocal, Ana, Téllez, Francisco, Díaz-Menéndez, Marta, Collado, Antonio, Pérez-Camacho, Inés, Delgado-Fernández, Marcial, Vera-Méndez, Francisco, Pineda, Juan A
Publicado no J Int AIDS Soc (2014)